Rowland Thomas Andrew 4
4 · ANI PHARMACEUTICALS INC · Filed Aug 14, 2025
Insider Transaction Report
Form 4
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
Transactions
- Sale
Common Stock
2025-08-12$85.71/sh−4,975$426,407→ 40,794 total
Footnotes (2)
- [F1]The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price.
- [F2]Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).